Johnson & Johnson
JNJ · NYSE
12/29/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $345,062 | $397,101 | $461,692 | $449,737 |
| - Cash | $24,105 | $21,859 | $12,889 | $14,487 |
| + Debt | $37,834 | $29,332 | $39,642 | $33,751 |
| Enterprise Value | $358,791 | $404,574 | $488,445 | $469,001 |
| Revenue | $88,821 | $85,159 | $79,990 | $78,740 |
| % Growth | 4.3% | 6.5% | 1.6% | – |
| Gross Profit | $61,350 | $58,606 | $55,394 | $55,338 |
| % Margin | 69.1% | 68.8% | 69.3% | 70.3% |
| EBITDA | $24,781 | $23,320 | $26,605 | $26,751 |
| % Margin | 27.9% | 27.4% | 33.3% | 34% |
| Net Income | $14,066 | $35,153 | $17,941 | $20,878 |
| % Margin | 15.8% | 41.3% | 22.4% | 26.5% |
| EPS Diluted | 5.79 | 13.72 | 6.73 | 7.81 |
| % Growth | -57.8% | 103.9% | -13.8% | – |
| Operating Cash Flow | $24,266 | $22,791 | $21,194 | $23,410 |
| Capital Expenditures | -$4,424 | -$4,543 | -$4,009 | -$3,652 |
| Free Cash Flow | $19,842 | $18,248 | $17,185 | $19,758 |